Report overview
This report contains market size and forecasts of Injectable Drug Delivery Formulation in global, including the following market information:
Global Injectable Drug Delivery Formulation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Drug Delivery Formulation Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Injectable Drug Delivery Formulation companies in 2021 (%)
The global Injectable Drug Delivery Formulation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Conventional Drug Delivery Formulations Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Drug Delivery Formulation include Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), Pfizer, Inc. (US), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel) and Eli Lilly and Company (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Drug Delivery Formulation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Drug Delivery Formulation Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, by Type, 2021 (%)
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations
Global Injectable Drug Delivery Formulation Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, by Application, 2021 (%)
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others
Global Injectable Drug Delivery Formulation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Drug Delivery Formulation revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Drug Delivery Formulation revenues share in global market, 2021 (%)
Key companies Injectable Drug Delivery Formulation sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Injectable Drug Delivery Formulation sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
